Long-Term Outcomes of Neovascular Glaucoma Treated With and Without Intravitreal Bevacizumab Olmos LC, Sayed MS, Moraczewski AL, et al Eye (Lond). 2015 Dec 18. [Epub ahead of print] ...

Vision loss from neovascular glaucoma (NVG) is a challenging condition to manage, as it can manifest abruptly and often results in poor visual prognosis even after timely surgical treatment.

It is intended to manage Neovascular Glaucoma by inhibiting abnormal blood vessel growth in the eye. This is a prospective, observational cohort study without random allocation or masking.

Neovascular glaucoma, a more severe form, arises from poor blood circulation in the eye due to conditions like diabetic retinopathy and blocked blood vessels.

The progression of vision loss among patients with neovascular glaucoma appeared linked to factors such as the disease stage at diagnosis, age, sex, a history of type 2 diabetes and insurance ...

Neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME) are two leading causes of vision loss in Canada1 VABYSMO® (faricimab injection) is the first bispecific ...